FDA Adverse Event
Malfunction
Summary report: N
NUVAGEN
MDR report key: 7038882
·
Received November 16, 2017
Report
- Report Number
- 1000526113-2017-70001
- Event Type
- Malfunction
- Date Received
- November 16, 2017
- Report Date
- November 8, 2017
- Manufacturer
- BELCHER PHARMACEUTICALS, LLC
- Product Code
- KOZ
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
Description of Event or Problem · 1
CASE DESCRIPTION: THIS SPONTANEOUS REPORT FROM A CONSUMER RECEIVED ON 08-NOV-2017 INVOLVED A/AN PATIENT, PATIENT INITIALS DD WHO STARTED TO RECEIVE[SUSPECT_NAMEMOD]. THE PATIENT'S MEDICAL HISTORY WAS NOT AVAILABLE. ON AN UNSPECIFIED DATE THE PATIENT RECEIVED FIRST DOSE OF[SUSPECT_NAMEMOD]:[1] AT ADMINISTERED VIA AN UNSPECIFIED ROUTE AT A DOSE OF FOR AN UNSPECIFIED INDICATION. THE PATIENT DEVELOPED/EXPERIENCED RASH. THE PATIENT'S LABORATORY TEST RESULTS WERE NOT AVAILABLE. (DESCRIBE MEDICATIONS, PROCEDURES, TESTS, INVESTIGATIONS ETC.) FOLLOWING [TREATMENT OR DECHALLENGE/RECHALLENGE]
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 815873 | NUVAGEN | NUVAGEN | KOZ | BELCHER PHARMACEUTICALS, LLC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |